CGON Overview
Upcoming Projects (CGON)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (CGON)
-
A Third Look: Discussing the cretostimogene grenadenorepvec data as it continues to demonstrate best-in-class durability of response as well as consistent and compelling safety and efficacy
Tickers: CGON, TARA, AURA, PFE
Executed On: Apr 11, 2025 at 08:15 AM EDT -
A Second Look: Discussing the cretostimogene grenadenorepvec data as it continues to demonstrate best-in-class durability of response as well as consistent and compelling safety and efficacy
Tickers: CGON, TARA, AURA, PFE
Executed On: Apr 10, 2025 at 05:00 PM EDT -
Discussing the cretostimogene grenadenorepvec data as it continues to demonstrate best-in-class durability of response as well as consistent and compelling safety and efficacy
Tickers: CGON, TARA, AURA, PFE
Executed On: Apr 09, 2025 at 12:00 PM EDT -
Discussing the Final Results from CORE-001 Phase 2 Trial of Cretostimogene Combined with Pembrolizumab for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer presented at 2024 ASCO Annual Meeting
Ticker: CGON
Executed On: Jun 04, 2024 at 04:00 PM EDT
Upcoming & Overdue Catalysts (CGON)
-
Don’t see a catalyst related to the company you care about? Create your own!
Strategic Initiatives (CGON)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
